Search research articles
Contact Us
Filters
Showing results (21-30 of 49) with videos related to
Page
of 5
Sort By:
Annals of the New York Academy of Sciences
|
February 24, 2001
Intraperitoneal topoisomerase-I inhibitors. Preliminary findings with 9-aminocamptothecin
F Muggia, L Liebes, M Potmesil, et al.
Analytical Biochemistry
|
June 13, 2001
High-performance liquid chromatography-based determination of total isothiocyanate levels in human plasma: application to studies with 2-phenethyl isothiocyanate
L Liebes, C C Conaway, H Hochster, et al.
Journal of Immunotherapy with Emphasis on Tumor Immunology : Official Journal of the Society for Biological Therapy
|
April 1, 1994
Monocyte activation following systemic administration of granulocyte-macrophage colony-stimulating factor
A Chachoua, R Oratz, R Hoogmoed, et al.
Transfusion
|
May 1, 1995
Hypericin as an inactivator of infectious viruses in blood components
G Lavie, Y Mazur, D Lavie, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
September 5, 2003
Complement activation following first exposure to pegylated liposomal doxorubicin (Doxil): possible role in hypersensitivity reactions
A Chanan-Khan, J Szebeni, S Savay, et al.
Gynecologic Oncology
|
September 1, 1989
Phase IB study of low-dose intraperitoneal recombinant interleukin-2 in patients with refractory advanced ovarian cancer: rationale and preliminary report
U Beller, A Chachoua, J L Speyer, et al.
Blood
|
October 15, 1992
Glutathione depletion in chronic lymphocytic leukemia B lymphocytes
R Silber, C M Farber, E Papadopoulos, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 24, 1999
Activity and pharmacodynamics of 21-Day topotecan infusion in patients with ovarian cancer previously treated with platinum-based chemotherapy. New York Gynecologic Oncology Group
H Hochster, S Wadler, C Runowicz, et al.
Journal of Immunotherapy with Emphasis on Tumor Immunology : Official Journal of the Society for Biological Therapy
|
August 1, 1994
Phase Ib trial of granulocyte-macrophage colony-stimulating factor combined with murine monoclonal antibody R24 in patients with metastatic melanoma
A Chachoua, R Oratz, L Liebes, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 10, 1999
Phase I trial of escalating doses of paclitaxel plus doxorubicin and dexrazoxane in patients with advanced breast cancer
J A Sparano, J Speyer, W J Gradishar, et al.
Page
of 5
Search research articles
Search
Showing results (21-30 of 49) with videos related to
Sort By:
Page
of 5
Annals of the New York Academy of Sciences
|
February 24, 2001
Intraperitoneal topoisomerase-I inhibitors. Preliminary findings with 9-aminocamptothecin
F Muggia, L Liebes, M Potmesil, et al.
Analytical Biochemistry
|
June 13, 2001
High-performance liquid chromatography-based determination of total isothiocyanate levels in human plasma: application to studies with 2-phenethyl isothiocyanate
L Liebes, C C Conaway, H Hochster, et al.
Journal of Immunotherapy with Emphasis on Tumor Immunology : Official Journal of the Society for Biological Therapy
|
April 1, 1994
Monocyte activation following systemic administration of granulocyte-macrophage colony-stimulating factor
A Chachoua, R Oratz, R Hoogmoed, et al.
Transfusion
|
May 1, 1995
Hypericin as an inactivator of infectious viruses in blood components
G Lavie, Y Mazur, D Lavie, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
September 5, 2003
Complement activation following first exposure to pegylated liposomal doxorubicin (Doxil): possible role in hypersensitivity reactions
A Chanan-Khan, J Szebeni, S Savay, et al.
Gynecologic Oncology
|
September 1, 1989
Phase IB study of low-dose intraperitoneal recombinant interleukin-2 in patients with refractory advanced ovarian cancer: rationale and preliminary report
U Beller, A Chachoua, J L Speyer, et al.
Blood
|
October 15, 1992
Glutathione depletion in chronic lymphocytic leukemia B lymphocytes
R Silber, C M Farber, E Papadopoulos, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 24, 1999
Activity and pharmacodynamics of 21-Day topotecan infusion in patients with ovarian cancer previously treated with platinum-based chemotherapy. New York Gynecologic Oncology Group
H Hochster, S Wadler, C Runowicz, et al.
Journal of Immunotherapy with Emphasis on Tumor Immunology : Official Journal of the Society for Biological Therapy
|
August 1, 1994
Phase Ib trial of granulocyte-macrophage colony-stimulating factor combined with murine monoclonal antibody R24 in patients with metastatic melanoma
A Chachoua, R Oratz, L Liebes, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 10, 1999
Phase I trial of escalating doses of paclitaxel plus doxorubicin and dexrazoxane in patients with advanced breast cancer
J A Sparano, J Speyer, W J Gradishar, et al.
Page
of 5